Why IMU is a multi multi bagger, page-24232

I am a holder for both RAC and another of Hopper companies....CHM

RAC isn't the only one that has gone through swings in Biotech, IMU is the same and so are many more....that had a huge increase in valuation at one time I think around 2021....

But relatively, RAC is trading at 50% of 2021 peak now while IMU is 1/10th of 2021 peak, so your point is?

RAC raise was great in an environment where markets were brutal irrespective of the fundamentals....They did an amazing job protecting SH value at the time when they needed money, a feat not a lot of biotech's were able to achieve....So you can talk it down as much as you want, but from RAC SH's perspective, it was a great outcome...

I have absolutely nothing against IMU, in fact I am looking to enter for last month or so...But my experience with CHM with Hopper involved and what's happening with RAD now definitely makes one thinks if he even cares...